# Development of a New Family of HIV Latency Regulators (LRAs) Targeting the Tat Viral Protein

> **NCT06441123** · — · RECRUITING · sponsor: **University Hospital, Montpellier** · enrollment: 24 (estimated)

## Conditions studied

- HIV Infections

## Interventions

- **BIOLOGICAL:** Blood Sampling

## Key facts

- **NCT ID:** NCT06441123
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-10
- **Primary completion:** 2027-02-10
- **Final completion:** 2027-02-10
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2025-02-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06441123

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06441123, "Development of a New Family of HIV Latency Regulators (LRAs) Targeting the Tat Viral Protein". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06441123. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
